Results 231 to 240 of about 6,382,615 (401)

La scuola medica Salernitana: Gli autori e i testi by Danielle Jacquart and Agostino Paravicini Bagliani edd. [PDF]

Aestimatio, 2008
Joseph Ziegler
doaj  

Research Trends and Prospects of Medical Anthropology: Concepts and Their Intersection with History of Medicine. [PDF]

Uisahak, 2020
Yoon E, Kim T.
europepmc   +1 more source

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

Molecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau, Hayley S. Smith, Begüm Alural, Claire E. Martin, Laura A. New, Manali Tilak, Sara L. Banerjee, Hannah N. Robeson, Nicolas Bisson, Anne‐Claude Gingras, Jasmin Lalonde, Nina Jones   +11 more
wiley   +1 more source

History of Military Medicine and Its Contributions to Science [PDF]

, 1917
Chamberlain
openalex   +1 more source

Interplay of integrins and selectins in metastasis

Molecular Oncology, EarlyView.
Here we review the role of integrins and their interplay with selectins in metastasis. The efficacy of integrin‐targeted therapies may be reduced in tumors where metastasis relies heavily on selectins. In certain tumors, integrins and selectins exhibit a synergistic interaction during intraperitoneal dissemination.
Diana Maltseva, Ashot Nersisyan, Alexander Tonevitsky   +2 more
wiley   +1 more source

The History of Clinical Medicine (Principally of Clinical Teaching) in the British Isles

, 1939
Humphry Rolleston
openalex   +1 more source

History and Ethics in Medicine [PDF]

, 1907
JAMES G. MUMFORD
openalex   +1 more source

Assessing the impact of history of medicine research: A scientometric and altmetric analysis. [PDF]

Health Sci Rep
Orimi JR, Asadi MH, Jafari F, Ramezani A, Hossein Latifi SA, Khosravi A, Mahmoodi SA, Salehi M, Siamian H.   +8 more
europepmc   +1 more source

A patients' history of medicine [PDF]

Clinical Medicine, 2007
openaire   +3 more sources

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source